Craniofacial Phenotypes and Genetics of DiGeorge Syndrome
Journal of Developmental Biology · 13.05.2022 · 10 (2) · 18
DOI: 10.3390/jdb10020018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Developmental Biology, online erschienen am 13.05.2022. Verfasst von Noriko Funato. Beteiligte Einrichtung: Department of Signal Gene Regulation, Advanced Therapeutic Sciences, Medical and Dental Sciences, Graduate School of Medical and Dental Sciences, Tok…. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The 22q11.2 deletion is one of the most common genetic microdeletions, affecting approximately 1 in 4000 live births in humans. A 1.5 to 2.5 Mb hemizygous deletion of chromosome 22q11.2 causes DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS). DGS/VCFS are associated with prevalent cardiac malformations, thymic and parathyroid hypoplasia, and craniofacial defects. Patients with DGS/VCFS manifest craniofacial anomalies involving the cranium, cranial base, jaws, pharyngeal muscles, ear-nose-throat, palate, teeth, and cervical spine. Most craniofacial phenotypes of DGS/VCFS are caused by proximal 1.5 Mb microdeletions, resulting in a hemizygosity of coding genes, microRNAs, and long noncoding RNAs. TBX1, located on chromosome 22q11.21, encodes a T-box transcription factor and is a candidate gene for DGS/VCFS. TBX1 regulates the fate of progenitor cells in the cranial and pharyngeal apparatus during embryogenesis. Tbx1-null mice exhibit the most clinical features of DGS/VCFS, including craniofacial phenotypes. Despite the frequency of DGS/VCFS, there has been a limited review of the craniofacial phenotypes of DGC/VCFS. This review focuses on these phenotypes and summarizes the current understanding of the genetic factors that impact DGS/VCFS-related phenotypes. We also review DGS/VCFS mouse models that have been designed to better understand the pathogenic processes of DGS/VCFS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Signal Gene Regulation, Advanced Therapeutic Sciences, Medical and Dental Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo 113-8510, Japan.
ORCID-Profile: Noriko Funato
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Funato, N. (2022). Craniofacial Phenotypes and Genetics of DiGeorge Syndrome. Journal of Developmental Biology, 10(2), 18. https://doi.org/10.3390/jdb10020018
Vancouver
Funato N. Craniofacial Phenotypes and Genetics of DiGeorge Syndrome. Journal of Developmental Biology. 2022;10(2):18. doi:10.3390/jdb10020018
BibTeX
@article{Funato2022,
author = {Funato, Noriko},
title = {Craniofacial Phenotypes and Genetics of DiGeorge Syndrome},
journal = {Journal of Developmental Biology},
year = {2022},
volume = {10},
number = {2},
pages = {18},
doi = {10.3390/jdb10020018}
}
EUVIMED